Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve
Automated decision-making The profiling described above is limited to advertising personalisation and does not produce legal effects or similarly significant effects within the meaning of Article 22 GDPR
The monthly membership includes: A new-patient evaluation with a provider, including labs (A1C, lipids, comprehensive metabolic panel, TSH, when indicated) A prescription for FDA-approved semaglutide (Wegovy) or tirzepatide (Zepbound) when clinically appropriate, billed through your pharmacy or, when feasible, the manufacturer's direct-pay channel Monthly follow-up visits to track weight, blood pressure, side effects, and dose titration Adjustments to other medications (blood pressure, diabetes, lipids) as your numbers improve A clear plan for what happens if you plateau, if side effects become a problem, or if your insurance changes A maintenance plan for after you hit your goal weight We don't promise quick fixes, before-and-after photos, or a specific number on the scale
At that point, we are preventing the onset of metabolic diseases rather than playing catch-up and treating them
